BPC-157 / TB-500

Description

BPC-157 and TB-500 Blend (10 mg) is a research-grade peptide formulation combining two synthetic peptides that have been widely investigated in preclinical models of tissue repair, cellular migration, angiogenesis, and regenerative biology

BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of Body Protection Compound (BPC), a protein identified in human gastric juice. It has been investigated primarily for its potential influence on tissue repair, angiogenesis, inflammatory signaling, and connective tissue biology. TB-500 is a synthetic peptide corresponding to the biologically active region of the naturally occurring protein Thymosin Beta-4 (Tβ4). Experimental studies suggest that Thymosin Beta-4 and its active fragments participate in cytoskeletal organization through interactions with G-actin, influencing cell migration, angiogenesis, wound repair, and tissue remodeling.

The combination of BPC-157 and TB-500 has attracted scientific interest because the peptides may influence complementary biological pathways involved in tissue regeneration.

Product Specifications

• High-purity peptides (≥99%)
• Enhanced results through synergistic action
• Lyophilized powder for reconstitution
• Ideal for advanced research in regenerative therapies
• 10mg BPC-157 + 10mg TB-500 per vial (Total = 20mg vial)
• Storage: −20 °C, protected from light and moisture

What Is It Used For and Its Purpose 

The BPC-157 and TB-500 Blend is intended as a laboratory research reagent for investigating biological processes involved in tissue repair, cellular migration, angiogenesis, and extracellular matrix remodeling. Researchers use this combination to study how multiple regenerative pathways may interact within experimental systems.

BPC-157 has primarily been investigated for its potential effects on connective tissue biology, gastrointestinal physiology, vascular responses, and inflammatory regulation. TB-500 has been studied for its role in actin dynamics, cellular motility, wound healing, and tissue remodeling through mechanisms associated with Thymosin Beta-4 biology.

Researchers may utilize the combined formulation to examine complementary biological responses in musculoskeletal tissues, vascular biology, and regenerative signaling. However, evidence supporting combined biological effects remains limited, and the pharmacological interactions between these peptides have not been comprehensively characterized.

Research Applications

• Regenerative medicine
• Musculoskeletal biology
• Angiogenesis research
• Connective tissue biology
• Wound healing
• Cell migration research
• Inflammation research
• Extracellular matrix biology
• Neurobiology
• Cardiovascular physiology

Potential Scientific Benefits 

BPC-157 has demonstrated biological activity in numerous in vitro and animal studies involving tendon repair, ligament healing, skeletal muscle regeneration, gastrointestinal mucosal protection, and peripheral nerve recovery. Proposed mechanisms include modulation of nitric oxide signaling, angiogenic pathways, inflammatory mediators, and extracellular matrix remodeling, although its primary molecular target remains incompletely characterized.

Experimental studies of Thymosin Beta-4 and TB-500 have reported effects on cytoskeletal organization through G-actin binding, facilitating cell migration and tissue remodeling. Animal models have demonstrated potential roles in wound closure, angiogenesis, inflammatory regulation, and connective tissue repair. These findings have contributed to ongoing research into regenerative biology and tissue engineering.

The rationale for combining BPC-157 with TB-500 is based on the hypothesis that modulation of multiple regenerative pathways may provide complementary experimental effects. However, published evidence evaluating the combined peptide formulation is limited. Most available scientific literature investigates each peptide independently rather than as a standardized combination.

Current understanding of this peptide blend is therefore based largely on extrapolation from separate preclinical studies. Robust clinical investigations evaluating efficacy, pharmacodynamics, safety, or potential synergistic mechanisms in humans are not currently available.

• Observed biological activities in research:
  • Enhanced tissue repair responses in experimental models
  • Promotion of angiogenesis
  • Increased cellular migration
  • Connective tissue remodeling
  • Modulation of inflammatory responses
• Molecular mechanisms reported:
  • Nitric oxide pathway modulation (BPC-157)
  • VEGF-associated angiogenic signaling
  • G-actin binding and cytoskeletal regulation (TB-500)
  • Extracellular matrix remodeling
  • Regulation of wound healing pathways
• Physiological pathways involved:
  • Tissue regeneration
  • Angiogenesis
  • Connective tissue remodeling
  • Cellular migration
  • Inflammatory signaling
  • Vascular biology
• Experimental outcomes in models:
  • Improved tendon and ligament healing
  • Accelerated wound closure
  • Enhanced vascularization
  • Increased fibroblast migration
  • Improved connective tissue remodeling

Current evidence remains limited, and further well-controlled clinical studies are required to establish long-term efficacy and safety in humans.

Research Data Sheet 

• Peptide name: BPC-157 and TB-500 Blend
• Sequence: BPC-157: GEPPPGKPADDAGLV; TB-500: Not consistently reported
• Classification: Synthetic peptide blend
• Molecular Formula: BPC-157: Not available; TB-500: C212H350N56O78S
• Molecular Weight: BPC-157: 1,419.54 g/mol; TB-500: 4,963.49 g/mol
• CAS Number: BPC-157: 137525-51-0; TB-500: Not available
• Form: Lyophilized powder
• Appearance: White to off-white lyophilized powder
• Purity: Not specified (selected batches HPLC tested)
• Solubility: Research-dependent; reconstitute with sterile bacteriostatic water or appropriate laboratory buffer
• Storage: -20°C lyophilized; 2–8°C after reconstitution (up to 14 days); aliquot and freeze for extended storage
• Research Categories: Regenerative medicine, musculoskeletal biology, angiogenesis, wound healing, connective tissue biology, inflammation research

Safety Precautions 

This peptide blend is supplied exclusively for laboratory research and should only be handled by qualified personnel using appropriate laboratory safety procedures. It is not approved for human consumption, veterinary use, diagnostic testing, or therapeutic applications.

The pharmacological profile and long-term safety of the combined peptide formulation have not been established in humans. Appropriate aseptic technique, storage conditions, labeling, and laboratory documentation should be maintained throughout all experimental procedures.

• Research use only
• Not for human consumption
• Not intended to diagnose, treat, or prevent disease
• Wear appropriate PPE (gloves, laboratory coat, and eye protection)
• Maintain aseptic handling procedures
• Store under recommended laboratory conditions
• Avoid repeated freeze–thaw cycles
• Maintain accurate labeling and documentation
• Dispose of materials according to institutional and regulatory requirements
• Limited human safety data
• Potential unknown long-term effects

Conclusion

The BPC-157 and TB-500 Blend combines two extensively investigated research peptides that have independently demonstrated biological activity in experimental models of tissue repair, angiogenesis, connective tissue remodeling, and regenerative biology. Their complementary mechanisms continue to generate scientific interest across multiple areas of translational research.

While preclinical findings suggest that both peptides influence cellular processes involved in wound healing, vascular biology, and tissue regeneration, evidence supporting the combined formulation remains limited. Most published data evaluate BPC-157 and TB-500 separately, and the biological interactions between the two peptides have not been comprehensively characterized. Its utility lies primarily in supporting ongoing research into regenerative medicine, connective tissue biology, angiogenesis, and molecular mechanisms of tissue repair.